dna demethylating

Eicosapentaenoic Acid is an ω-3 fatty acid and an inhibitor of fatty acid synthase (FASN). Eicosapentaenoic Acid promotes DNA demethylation in the reexpression of the tumor suppressor gene CCAAT/ enhancer-binding protein δ (C/EBPδ). Eicosapentaenoic Acid activates the RAS/ERK/C/EBPβ pathway in U937 leukemia cells through demethylation of the CpG island of H-RAS intron 1. Eicosapentaenoic Acid promotes the relaxation of vascular smooth muscle cells and vasodilation.

Isofistularin-3, a direct DNA-competitive DNMT1 inhibitor with an IC50 of 13.5 μM, functions as a DNA demethylating agent, leading to cell cycle arrest and increased sensitivity to TRAIL in cancer cells. Additionally, it can be employed as an ADC cytotoxin.

Eicosapentaenoic Acid (EPA) sodium, an orally active omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA), demonstrates a unique ability to demethylate DNA, thereby facilitating the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein δ (C/EBPδ). This compound also activates the RAS/ERK/C/EBPβ pathway by demethylating H-Ras intron 1 CpG island in U937 leukemia cells and promotes the relaxation of vascular smooth muscle cells, leading to vasodilation.

UBS109, a curcumin analogue, is a DNA demethylating agent in pancreatic cancer, promotes osteoblast differentiation and mineralization, inhibits breast cancer metastasis to the lungs, and prevents bone loss induced by breast cancer cell lines.

Procainamide-d4 (Procaine amide-d4) is a deuterium-labeled version of Procainamide, which is a potent and specific inhibitor of DNA methyltransferase 1 (DNMT1). It reactivates tumor suppressor gene expression by demethylating these genes. Procainamide induces vacuolization in various cell types and reduces cell proliferation and migration. Additionally, it relaxes tracheal smooth muscle by activating the potassium channel and is applicable in research related to cancer and arrhythmia.